Rosudex 20mg tablets
Dexa Medica
Ingredients in every tablet
| Rosuvastatin | 20 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | C - Cardiovascular system |
| ATC Level 2 | C10 - Lipid Modifying Agents |
| ATC Level 3 | C10A - Lipid Modifying Agents; Plain |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Cambodia |
Dosage information
18 YEARS OLD AND ABOVE
the recommended dose is 5 or 10 mg orally once daily. A dose adjusment to the next dose level can be made after 4 weeks, if necessary.
n light of the increased reporting rate of adverse reactions with the 40 mg dose compared to lower doses, a final titration to the maximum dose of 40 mg should only be considered in patients with severe hypercholesterolemia at high cardiovascular risk (in particular those with familial hypercholesterolemia), who do not achieve their treatment goal on 20 mg, and in whom routine follow-up will be performed.
The choice of starting dose should take into account the individual patient’s cholesterol level and future cardiovascular risk as well as the potential risk for adverse reactions.
Rosuvastatin may be given at any time of day, with or without food.
0 TO 18 YEARS OLD
Not recommended
The choice of starting dose should take into account the individual patient’s cholesterol level and future cardiovascular risk as well as the potential risk for adverse reactions.
Rosuvastatin may be given at any time of day, with or without food.
Indication
Patients with primary hypercholesterolemia or mixed dyslipidemia (type IIb) as an adjunct to diet when response to diet and exercise is inadequate. Rosuvastatin reduces elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB and increases HDL cholesterol.